RBC Capital Sticks to Their Buy Rating for DRI Healthcare (DHT.UN) | Markets Insider
RBC Capital analyst Douglas Miehm maintained a Buy rating on DRI Healthcare (DHT.UN – Research Report) yesterday and set a price target of C$18.00. The company’s shares closed yesterday at C$12.48.
Miehm covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Ligand Pharma, and Bausch Health Companies. According to TipRanks, Miehm has an average return of -2.3% and a 39.85% success rate on recommended stocks.
Currently, the analyst consensus on DRI Healthcare is a Strong Buy with an average price target of C$16.67, a 33.57% upside from current levels. In a report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a C$17.00 price target.
DHT.UN market cap is currently C$698.3M and has a P/E ratio of 338.80.
